MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Canon Europe Acquires Medical Imaging Technology Company Delft DI

By MedImaging International staff writers
Posted on 07 Feb 2012
Print article
Canon Europe (London, UK), a world-leading developer of imaging technology, has strengthened its product range in the medical imaging field by acquiring medical solutions company Delft Diagnostic Imaging (Delft DI; Veenendaal, The Netherlands).

Delft DI specializes in two business fields. The first is software solutions for sharing digital images and medical records. This business will become a future platform for the development of new healthcare information and communication technology (ICT) system including cross enterprise document sharing for imaging (XDSI) solutions. The second is digital X-ray imaging systems, systems integration, and service of a wide variety of customized complete solutions for radiology departments.

Delft DI has been an important distribution partner for Canon digital radiography systems for over 10 years in The Netherlands and Belgium. Building on this partnership, where Delft DI has already integrated Canon digital radiography products in their services, this business will become a platform for developing future digital radiography services.

Ryoichi Bamba, president and CEO, Canon Europe, said, “Canon has identified medical imaging as an important focus area for future growth, and we believe this investment and expansion of the medical business will bring new opportunities to build on our success in the digital radiography and eye care sectors to date. We are excited about the solutions and services we can bring to the market together with Delft DI for the benefit of our customers and ultimately patient care. We are looking forward to welcoming Delft DI into the Canon group.”

Guido Geerts, chief executive officer, Delft DI, added, “We have enjoyed a good relationship with Canon as a distribution partner and we are delighted to now be extending this relationship. We are proud to become part of the Canon Group and believe this will also bring benefits for our customers.”

Following the completion of the acquisition, Delft DI will become a subsidiary of Canon Europa NV. Yoshiyuki Masuko, senior director, medical imaging group, will join the board of Delft DI. Delft Imaging Systems, currently a subsidiary of Delft DI, will become a separate company, will no longer be part of Delft DI group, and is not part of this acquisition.

Delft DI specializes in novel medical picture archiving and communication system (PACS) software solutions, digital X-ray imaging systems, and system integration and service of a wide range of customized complete solutions for radiology departments. Delft DI includes Rogan-Delft, Delft Imaging Systems, and Oldelft Benelux.

Canon is a developer of medical applications. In 1940, Canon’s first medical application was introduced, an X-ray application for tuberculosis screening. Canon has delivered many of the world’s first systems in the area of radiography and eye care. Today, Canon’s broad line of digital radiography systems and eye care diagnostic equipment is used in many areas including hospital environments, medical and screening centers, as well as a wide range of portable needs systems.

Related Links:
Canon Europe
Delft Diagnostic Imaging



Ultrasonic Pocket Doppler
SD1
Digital Radiographic System
OMNERA 300M
New
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices
3T MRI Scanner
MAGNETOM Cima.X

Print article

Channels

MRI

view channel
Image: The AI tool can help interpret and assess how well treatments are working for MS patients (Photo courtesy of Shutterstock)

AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans

Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more